Cambridge Investment Research Advisors
ISRG icon

Cambridge Investment Research Advisors’s Intuitive Surgical ISRG Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19M Sell
41,117
-1,019
-2% -$516K 0.05% 390
2025
Q4 		$23.9M Buy
42,136
+2,636
+7% +$1.4M 0.06% 304
2025
Q3 		$17.7M Sell
39,500
-201
-0.5% -$96.5K 0.05% 389
2025
Q2 		$21.6M Buy
39,701
+6,954
+21% +$3.64M 0.07% 293
2025
Q1 		$16.2M Buy
32,747
+1,480
+5% +$818K 0.05% 348
2024
Q4 		$16.3M Buy
31,267
+1,950
+7% +$1.02M 0.05% 327
2024
Q3 		$14.4M Buy
29,317
+2,951
+11% +$1.37M 0.05% 379
2024
Q2 		$11.7M Sell
26,366
-6,567
-20% -$2.62M 0.04% 411
2024
Q1 		$13.1M Buy
32,933
+6,570
+25% +$2.48M 0.05% 359
2023
Q4 		$8.89M Sell
26,363
-932
-3% -$278K 0.04% 451
2023
Q3 		$7.98M Buy
27,295
+3,589
+15% +$1.12M 0.04% 448
2023
Q2 		$8.11M Sell
23,706
-3,362
-12% -$1.02M 0.04% 451
2023
Q1 		$6.92M Sell
27,068
-332
-1% -$81.8K 0.03% 482
2022
Q4 		$7.27M Sell
27,400
-10,486
-28% -$2.56M 0.04% 455
2022
Q3 		$7.1M Buy
37,886
+223
+0.6% +$47.9K 0.04% 424
2022
Q2 		$7.56M Buy
37,663
+1,619
+4% +$380K 0.04% 422
2022
Q1 		$10.9M Sell
36,044
-1,486
-4% -$434K 0.05% 350
2021
Q4 		$13.5M Buy
37,530
+1,968
+6% +$677K 0.06% 292
2021
Q3 		$11.8M Sell
35,562
-1,521
-4% -$511K 0.06% 317
2021
Q2 		$11.4M Buy
37,083
+882
+2% +$247K 0.05% 330
2021
Q1 		$8.92M Buy
36,201
+3,414
+10% +$859K 0.05% 364
2020
Q4 		$8.94M Buy
32,787
+669
+2% +$166K 0.05% 331
2020
Q3 		$7.6M Sell
32,118
-3,975
-11% -$893K 0.05% 341
2020
Q2 		$6.86M Buy
36,093
+3,021
+9% +$542K 0.05% 339
2020
Q1 		$5.46M Buy
33,072
+8,085
+32% +$1.48M 0.05% 341
2019
Q4 		$4.92M Sell
24,987
-2,253
-8% -$422K 0.04% 473
2019
Q3 		$4.9M Buy
27,240
+1,719
+7% +$297K 0.04% 414
2019
Q2 		$4.46M Buy
25,521
+2,874
+13% +$492K 0.04% 430
2019
Q1 		$4.31M Buy
22,647
+420
+2% +$74.6K 0.04% 416
2018
Q4 		$3.55M Buy
22,227
+6,342
+40% +$1.07M 0.04% 436
2018
Q3 		$3.04M Buy
15,885
+2,571
+19% +$457K 0.03% 520
2018
Q2 		$2.12M Sell
13,314
-354
-3% -$54K 0.02% 629
2018
Q1 		$1.88M Buy
13,668
+2,373
+21% +$331K 0.02% 645
2017
Q4 		$1.37M Buy
11,295
+711
+7% +$89K 0.02% 753
2017
Q3 		$1.23M Buy
10,584
+1,188
+13% +$129K 0.02% 740
2017
Q2 		$977K Sell
9,396
-7,821
-45% -$752K 0.01% 821
2017
Q1 		$1.47M Sell
17,217
-270
-2% -$21.3K 0.03% 569
2016
Q4 		$1.23M Buy
17,487
+3,186
+22% +$234K 0.02% 588
2016
Q3 		$1.15M Buy
14,301
+963
+7% +$73.7K 0.02% 622
2016
Q2 		$980K Buy
13,338
+6,984
+110% +$491K 0.02% 604
2016
Q1 		$424K Sell
6,354
-1,809
-22% -$112K 0.01% 981
2015
Q4 		$495K Buy
8,163
+1,962
+32% +$110K 0.01% 853
2015
Q3 		$317K Buy
6,201
+135
+2% +$7.65K 0.01% 998
2015
Q2 		$327K Sell
6,066
-918
-13% -$51.4K 0.01% 1018
2015
Q1 		$392K Sell
6,984
-297
-4% -$16.8K 0.01% 921
2014
Q4 		$428K Sell
7,281
-216
-3% -$12K 0.01% 856
2014
Q3 		$385K Buy
7,497
+387
+5% +$19.2K 0.01% 946
2014
Q2 		$325K Sell
7,110
-10,809
-60% -$477K 0.01% 976
2014
Q1 		$872K Buy
17,919
+11,880
+197% +$560K 0.03% 472
2013
Q4 		$258K Sell
6,039
-702
-10% -$29.5K 0.01% 952
2013
Q3 		$282K Sell
6,741
-1,287
-16% -$56.8K 0.01% 862
2013
Q2 		$451K Buy
+8,028
New +$442K 0.02% 587

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cambridge Investment Research Advisors's ISRG Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Intuitive Surgical (ISRG) stake by 2.4% in Q1 2026, selling an estimated $516K and leaving 41,117 shares worth $19M. The position accounts for 0.05% of the portfolio, ranked #390.

Cambridge Investment Research Advisors first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.9M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Cambridge Investment Research Advisors held 41,117 shares of Intuitive Surgical worth $19M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 1,019 Intuitive Surgical shares in Q1 2026, an estimated $516K.
  • Intuitive Surgical made up 0.05% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #390 holding.
  • Cambridge Investment Research Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
  • Cambridge Investment Research Advisors's Intuitive Surgical position peaked at $23.9M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.